Drugs / Verapamil ER
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 4 | NCT03150524 Comparator | Jul 2017 → May 2019 | reversible cerebral vasoconstriction syndrome | Johns Hopkins University | Withdrawn | No outcome recorded |
Evidence & citations 1 cited value
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Verapamil ER | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03150524 ↗ |